Document is current
Any future updates will be listed below
-
Authors
Friedman, Sam F. https://orcid.org/0000-0002-0688-2169
Khurshid, Shaan https://orcid.org/0000-0002-2840-4539
Venn, Rachael A.
Wang, Xin
Diamant, Nate
Di Achille, Paolo https://orcid.org/0000-0001-9256-0678
Weng, Lu-Chen https://orcid.org/0000-0003-1475-4930
Choi, Seung Hoan https://orcid.org/0000-0002-2797-3190
Reeder, Christopher https://orcid.org/0000-0002-3893-2423
Pirruccello, James P. https://orcid.org/0000-0001-6088-4037
Singh, Pulkit https://orcid.org/0000-0002-1538-5519
Lau, Emily S. https://orcid.org/0000-0001-9361-6397
Philippakis, Anthony https://orcid.org/0000-0001-6953-3794
Anderson, Christopher D.
Maddah, Mahnaz https://orcid.org/0000-0002-9837-6000
Batra, Puneet
Ellinor, Patrick T. https://orcid.org/0000-0002-2067-0533
Ho, Jennifer E. https://orcid.org/0000-0002-7987-4768
Lubitz, Steven A. https://orcid.org/0000-0002-9599-4866
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 21 December 2024
First Online: 12 January 2025
Competing interests
: Dr. Lubitz is a full-time employee of Novartis Institutes for Biomedical Research as of July 18, 2022. Dr. Lubitz has received sponsored research support from Bristol Myers Squibb, Pfizer, Boehringer Ingelheim, Fitbit, Medtronic, Premier, and IBM, and has consulted for Bristol Myers Squibb, Pfizer, Blackstone Life Sciences, and Invitae. Dr. Anderson receives sponsored research support from Bayer AG and Massachusetts General Hospital and has consulted for ApoPharma. Dr. Weng receives sponsored research support from IBM to the Broad Institute. Dr. Ellinor has received sponsored research support from Bayer AG and IBM Health, and he has consulted for Bayer AG, Novartis and MyoKardia. Dr. Batra, Dr. Reeder and Dr. Friedman have received sponsored research support from Bayer AG and IBM Health. Dr. Ho and Dr. Khurshid have received sponsored research support from Bayer AG. The remaining authors declare no competing interests.
